Published by Iain Gilbert on 11th August 2026
(Sharecast News) - Analysts at Berenberg raised their price target for Hikma Pharmaceuticals from 1,800p to 2,100p on Tuesday, saying the business was "moving in the right direction" following a stronger‑than‑expected first half.
URL: http://www.digitallook.com/dl/news/story/36132850/...